Kroger Co. (KR) Financials Nov 14, 2014, 5:47 p.m.
Income
Kroger Co. (KR) Financials Nov 14, 2014, 5:47 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Kroger Co.
Fiscal year is February-January. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 76.61B 82.05B 90.37B 96.75B 98.38B
Cost of Goods Sold (COGS) incl. D&A 60.37B 65.4B 73.13B 78.51B 79.86B
COGS excluding D&A 58.85B 63.8B 71.49B 76.86B 78.14B
Depreciation & Amortization Expense 1.53B 1.6B 1.64B 1.65B 1.72B
Depreciation 1.53B 1.6B - - 1.7B
Amortization of Intangibles - - - - 18M
Gross Income 16.24B 16.65B 17.24B 18.24B 18.52B
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 14.1B 14.53B 16.04B 15.57B 15.83B
Research & Development 0 0 0 0 0
Other SG&A 14.1B 14.53B 16.04B 15.57B 15.83B
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.16B 37M 34M 29M 65M
EBIT after Unusual Expense (1.16B) (37M) (34M) (29M) (65M)
Non Operating Income/Expense 111M 109M 109M 112M 106M
Non-Operating Interest Income - - 0 0 0
Equity in Affiliates (Pretax) - - - - -
Interest Expense 502M 454M 435M 451M 444M
Gross Interest Expense 512M 461M 441M 454M 449M
Interest Capitalized 10M 7M 6M 3M 5M
Pretax Income 589M 1.73B 843M 2.3B 2.28B
Income Tax 532M 601M 247M 794M 751M
Income Tax - Current Domestic 234M 792M 188M 609M 680M
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 298M (191M) 59M 185M 71M
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 (4M) (12M) (12M)
Consolidated Net Income 57M 1.13B 592M 1.5B 1.52B
Minority Interest Expense (13M) 17M (6M) 11M 12M
Net Income 70M 1.12B 598M 1.49B 1.51B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - - 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 70M 1.12B 598M 1.49B 1.51B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 70M 1.12B 598M 1.49B 1.51B
EPS (Basic) 0.11 1.76 1.01 2.78 2.93
Basic Shares Outstanding 647M 635M 590M 533M 514M
EPS (Diluted) 0.11 1.74 1.01 2.77 2.90
Diluted Shares Outstanding 650M 638M 593M 537M 520M
EBITDA 3.67B 3.72B 2.84B 4.32B 4.41B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Dollars and Sense: Affordable Cars in Raleigh Listen up, folks. These days, unless you're on the hunt for a fancy ride decked out with every bell and whistle, the idea of nabbing a car under ten grand almost sounds like a fairytale. But Auction Direct USA in Raleigh is making this dream a reality. That’s right, a whole fleet of used cars, all priced under $10,000, is...
Continue Reading
Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...
Continue Reading
The True Stories Behind Exorcisms In the complex landscape of media today, EWTN Studio's latest docuseries, In Jesus' Name, steps into the ring with tales that outstrip Hollywood's beloved fright flicks. Forget about the jumpscares and the special effects next to those greased-up eggs you're munching on. This series drills right to the bone of reality—a candid look at...
Continue Reading
Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...
Continue Reading
Record Financing Applications, But Not All is Rosy Diving headlong into this 1West data is like clutching at a double-edged sword. On one side, we've got record-breaking numbers—48,975 financing applications in Q3 alone. That’s a staggering 25% hike over last year. But before you pop the champagne, let's pivot to the other edge: dwindling financial health. With the...
Continue Reading
Stepping up to Spotlight Courage In a world that often seems to teeter on chaos, it's those unsung heroes—the first responders—who stand ready to turn panic into repose. October 28th saw Times Square in New York City transform into a beacon of appreciation as the First Responders Children's Foundation (FRCF) applauded nineteen fearless foes of danger. Picture that...
Continue Reading
Electricity Powerhouse Unleashes Ambitious Plan If you thought American Electric Power (NASDAQ:AEP) was just cruising along, think again. This week, they rolled out an eye-popping $100 billion plan to supercharge their infrastructure and meet soaring electricity demands. It’s like they’re building the future of power right in front of our eyes. Third-quarter earnings...
Continue Reading
Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...
Continue Reading
Cloopen Steps Away from Public Market Scene Here's a tale simmering on the corporate backburner: Cloopen Group Holding Limited, that cloud juggernaut over in China, has gone all private on us. The ink is drying on their merger with SummerX Holdings Limited, under the overarching umbrella of SpringX Holdings. So, now this communications outfit has slipped out of the public...
Continue Reading
Ever stood in a place where history feels so heavy you can almost touch it? That's Lazikou, a gorge in southern Gansu, where ninety years ago, young soldiers of China's Red Army faced a seemingly impassable barrier. Yet, they managed to climb, transform a military retreat into legend, and essentially shape the nation's path ahead. It's a feat that still sends ripples...
Continue Reading
Top 5 Most Recently Viewed Articles
Aeroderivative Gas Turbine Market Overview The Aeroderivative Gas Turbine market is experiencing remarkable growth, driven by increasing demands for efficient power generation and technological innovations. According to recent analysis, the market is projected to surge to an estimated value of USD 6.79 billion by 2034, marking a compound annual growth rate (CAGR) of...
Continue Reading
Chain.io Unveils New Snowflake Connectivity Chain.io has introduced an exciting connected application aimed at boosting the capabilities of supply chain teams. This innovative tool provides seamless access to supply chain data, paving the way for deeper insights and improved operational efficiency. Navigating the Complexities of Supply Chain Data Logistics and supply...
Continue Reading
Antalpha's Impressive Third Quarter Performance Antalpha Platform Holding Company (NASDAQ: ANTA) has recently unveiled promising financial results for the third quarter of this year. This period has proven pivotal as the company marked an extraordinary 62% growth in revenue over the previous year, highlighting the effectiveness of their Prime lending platform. Rapid...
Continue Reading
Understanding Class Actions and Your Rights If you've faced losses in your investments with Block, Inc. (XYZ), you may feel overwhelmed and uncertain about your next steps. Class action lawsuits can be an effective way for shareholders like you to seek justice and accountability from companies. The Gross Law Firm is reaching out to encourage affected investors to take...
Continue Reading
Acumen Pharmaceuticals Advances in Alzheimer’s Research Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is at the forefront of developing a promising new treatment aimed at combating Alzheimer's disease. This innovative approach focuses on targeting soluble amyloid beta oligomers (A?Os), a significant physiological...
Continue Reading